During the treatment of chronic myeloid leukemia, cytogenetic is least likely to occur with which one of the following modalities of treatment ?: (A) Hydroxyurea, (B) Imatinib mesylate, (C) Interferon-alpha, (D) Bone marrow transplantation
Answer is A. None